• 1
    Centers for Disease Control and Prevention (CDC). Racial/ethnic disparities in prevalence, treatment, and control of hypertension – United States, 1999–2002. MMWR Morb Mortal Wkly Rep. 2005;54(1):79.
  • 2
    Lloyd-Jones D, Adams RJ, Brown TM, et al. Heart disease and stroke statistics—2010 update: a report from the American Heart Association. Circulation. 2010;121(7):e46e215.
  • 3
    Preventing Cardiovascular Disease in Maryland: Public Health Strategies. Baltimore, MD: Maryland Department of Health and Mental Hygiene, Family Health Administration, Office of Chronic Disease Prevention; 2003.
  • 4
    Maryland Vital Statistics: Annual Report 2001. Baltimore, MD; Maryland Department of Health and Mental Hygiene, Vital Statistics Administration; 2001.
  • 5
    State Health Facts Online. The Henry J. Kaiser family foundation. Accessed February 17, 2004.
  • 6
    Egan BM, Zhao Y, Axon RN. US trends in prevalence, awareness, treatment, and control of hypertension, 1988–2008. JAMA. 2010;303(20):20432050.
  • 7
    Levine DM, Green LW, Deeds SG, et al. Health education for hypertensive patients. JAMA. 1979;241(16):17001703.
  • 8
    Brownstein JN, Chowdhury FM, Norris SL, et al. Effectiveness of community health workers in the care of people with hypertension. Am J Prev Med. 2007;32(5):435447.
  • 9
    Wright JT Jr, Bakris G, Greene T, et al. Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial. JAMA. 2002;288(19):24212431.
  • 10
    Pickering TG, Hall JE, Appel LJ, et al. Recommendations for blood pressure measurement in humans and experimental animals: Part 1: blood pressure measurement in humans: a statement for professionals from the subcommittee of professional and public education of the American Heart Association Council on High Blood Pressure Research. Hypertension. 2005;45(1):142161.
  • 11
    Health People 2010. http://wwwhealthypeoplegov/. Accessed October 27, 2010.
  • 12
    McLean DL, McAlister FA, Johnson JA, et al. A randomized trial of the effect of community pharmacist and nurse care on improving blood pressure management in patients with diabetes mellitus: study of cardiovascular risk intervention by pharmacists-hypertension (SCRIP-HTN). Arch Intern Med. 2008;168(21):23552361.
  • 13
    Carter BL, Rogers M, Daly J, et al. The potency of team-based care interventions for hypertension: a meta-analysis. Arch Intern Med. 2009;169(19):17481755.
  • 14
    Ogedegbe G, Tobin JN, Fernandez S, et al. Counseling African Americans to control hypertension (CAATCH) trial: a multi-level intervention to improve blood pressure control in hypertensive blacks. Circ Cardiovasc Qual Outcomes. 2009;2(3):249256.
  • 15
    Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension. 2003;42(6):12061252.
  • 16
    Lewington S, Clarke R, Qizilbash N, et al. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360(9649):19031913.
  • 17
    Svetkey LP, Pollak KI, Yancy WS Jr, et al. Hypertension improvement project: randomized trial of quality improvement for physicians and lifestyle modification for patients. Hypertension. 2009;54(6):12261233.
  • 18
    Carter BL, Ardery G, Dawson JD, et al. Physician and pharmacist collaboration to improve blood pressure control. Arch Intern Med. 2009;169(21):19962002.